biotech semaglutide JPMorgan is getting in on the Ozempic craze with a $500 million fund Semaglutide (For R&D) | Readline
Description
Jackson S E
"Thiamine and GLP-1 Medications." Available at: Note for Readers: This article is for educational purposes only and should not be considered medical advice
Who might that be, you ask
This mechanism is particularly relevant for people with polycystic ovary syndrome (PCOS), a condition characterised by insulin resistance, hyperandrogenism, and often troublesome acne
Better imaging could have downstream effects on both care and clinical trials
